A Double-Blind, Randomized, Placebo-Controlled Trial To Evaluate The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Immune globulin (Primary) ; Albumins
- Indications Diabetic neuropathies; Neurogenic pain
- Focus Therapeutic Use
- 11 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 1 Sep 2017.
- 17 May 2017 Planned initiation date changed from 1 May 2017 to 1 Jul 2017.
- 12 Apr 2017 Status changed from recruiting to not yet recruiting.